Medicines in Development for Cancer in 2012: An Excellent Response from America’s Biopharmaceutical Research Companies

Reported by: Dr. Venkat S. Karra, Ph.D. Cancer remains the second leading cause of death by disease. Hundreds of new medicines to treat cancer are now being developed for lessening the burden of cancer to patients, their families and society. Biopharmaceutical researchers are now working on 981 medicines for cancer. Many are high-tech weapons to fight the disease, while some involve innovative … Continue reading Medicines in Development for Cancer in 2012: An Excellent Response from America’s Biopharmaceutical Research Companies